Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers, Published online: 16 May 2018; doi:10.1038/s41416-018-0082-1
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancershttps://ift.tt/2Ij3MDE
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου